13 | Carbon-11IBA
08/2020
-
01/2005 |
11 | EnzymesIBA
01/2019
-
11/2004 |
6 | Biological ProductsIBA
09/2011
-
10/2002 |
5 | Estrogen ReceptorsIBA
06/2020
-
01/2007 |
5 | Proteins (Proteins, Gene)FDA Link
11/2011
-
02/2003 |
4 | Biomarkers (Surrogate Marker)IBA
01/2017
-
03/2004 |
4 | O(6)-benzylguanineIBA
10/2005
-
02/2003 |
3 | Aromatase (CYP19)IBA
12/2010
-
01/2007 |
3 | Antineoplastic Agents (Antineoplastics)IBA
03/2010
-
11/2004 |
3 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2006
-
10/2005 |
3 | Fluorine-18IBA
11/2006
-
11/2004 |
3 | purineIBA
06/2005
-
05/2003 |
2 | Phosphodiesterase 5 InhibitorsIBA
08/2020
-
12/2019 |
2 | Tyrosine (L-Tyrosine)FDA Link
12/2019
-
01/2006 |
2 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
12/2014
-
03/2010 |
2 | sulfamic acid (ammonium sulfamate)IBA
07/2012
-
11/2009 |
2 | Steryl-Sulfatase (Steroid Sulfatase)IBA
07/2012
-
11/2009 |
2 | Celecoxib (Celebrex)FDA Link
09/2011
-
11/2009 |
2 | Dopamine (Intropin)FDA LinkGeneric
06/2011
-
06/2005 |
2 | 1,2,3,4-tetrahydroisoquinolineIBA
10/2008
-
10/2007 |
2 | EstersIBA
01/2006
-
01/2005 |
2 | Alkyl and Aryl TransferasesIBA
10/2005
-
05/2003 |
2 | PurinesIBA
06/2005
-
05/2003 |
2 | Choline (Choline Chloride)IBA
06/2004
-
11/2002 |
2 | Matrix Metalloproteinase InhibitorsIBA
10/2003
-
10/2002 |
1 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2021 |
1 | TPN171IBA
08/2020 |
1 | 16-fluoroestradiolIBA
06/2020 |
1 | RadiopharmaceuticalsIBA
06/2020 |
1 | Estrogen Receptor Modulators (Antiestrogen)IBA
06/2020 |
1 | Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2020 |
1 | Amino AcidsFDA Link
12/2019 |
1 | pyrimidineIBA
02/2018 |
1 | Glycogen Synthase Kinase 3IBA
01/2017 |
1 | Purinergic P2X4 ReceptorsIBA
01/2017 |
1 | Purinergic P2X7 ReceptorsIBA
01/2017 |
1 | Purinergic Receptors (Receptors, Purine)IBA
01/2017 |
1 | proto-oncogene proteins pimIBA
09/2015 |
1 | Protein Disulfide-IsomerasesIBA
04/2013 |
1 | benzamideIBA
02/2013 |
1 | benzocycloheptapyridineIBA
02/2013 |
1 | (11C)J147IBA
01/2013 |
1 | DNA (Deoxyribonucleic Acid)IBA
08/2012 |
1 | DNA-Activated Protein KinaseIBA
08/2012 |
1 | DNA Repair EnzymesIBA
08/2012 |
1 | Carbonic Anhydrase IIIBA
07/2012 |
1 | Sulfates (Sulfates, Inorganic)IBA
07/2012 |
1 | SteroidsIBA
07/2012 |
1 | Estradiol (Delestrogen)FDA LinkGeneric
07/2012 |
1 | Estrogens (Estrogen)FDA Link
07/2012 |
1 | ZincIBA
07/2012 |
1 | omipalisibIBA
02/2012 |
1 | Androgen Receptors (Androgen Receptor)IBA
12/2011 |
1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2011 |
1 | NitrogenIBA
06/2011 |
1 | Oxygen (Dioxygen)IBA
06/2011 |
1 | Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
06/2011 |
1 | vandetanib (ZD6474)IBA
06/2011 |
1 | Cholinesterases (Cholinesterase)IBA
04/2011 |
1 | Carbolines (Beta-Carbolines)IBA
04/2011 |
1 | NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
12/2010 |
1 | 6- methoxy- 9- methyl- (1,3)dioxolo(4,5- h)quinolin- 8(9H)- oneIBA
12/2010 |
1 | LipidsIBA
10/2010 |
1 | CholesterolIBA
10/2010 |
1 | 3- (1- methyl- 1H- indol- 3- yl)- 4- (1- methyl- 6- nitro- 1H- indol- 3- yl)- 1H-pyrrole-2,5-dioneIBA
10/2010 |
1 | tariquidar (XR9576)IBA
06/2010 |
1 | indoleIBA
04/2010 |
1 | latrepirdine (dimebon)IBA
04/2010 |
1 | CB2 Cannabinoid ReceptorIBA
03/2010 |
1 | CannabinoidsIBA
03/2010 |
1 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2009 |
1 | DAA 1106IBA
06/2009 |
1 | GABA-A Receptors (GABA(A) Receptor)IBA
06/2009 |
1 | methyl ester (1R- (exo,exo))- 3- (4- fluorophenyl)- 8- methyl- 8- azabicyclo(3.2.1)octane-2-carboxylic acidIBA
01/2009 |
1 | afimoxifene (hydroxytamoxifen)IBA
10/2008 |
1 | Selective Estrogen Receptor Modulators (SERM)IBA
10/2008 |
1 | Rivastigmine (Exelon)FDA LinkGeneric
04/2008 |
1 | Acetates (Acetic Acid Esters)FDA Link
04/2008 |
1 | ButyrylcholinesteraseIBA
04/2008 |
1 | CyclofenilIBA
04/2008 |
1 | AcetylcholinesteraseIBA
04/2008 |
1 | methyl-laudanosineIBA
02/2008 |